Home > Boards > US Listed > Cannabis > Cronos Group Inc. (CRON)

$CRON get NICE mention in new report on

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Brodmann Member Profile
Member Level 
Followed By 60
Posts 3,020
Boards Moderated 3
Alias Born 06/28/17
160x600 placeholder
Searching for the Next Super Nova NetworkNewsWire - 6/17/2019 8:45:00 AM
Dramatically Improved Delivery Systems Promise More Effective Cannabis Treatments NetworkNewsWire - 6/11/2019 8:45:00 AM
Cannabis Stocks You Should Know- THC Therapeutics, Inc. (THCT) InvestorsHub NewsWire - 6/3/2019 10:15:08 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/30/2019 11:01:46 AM
Cronos Group Inc. to Present at Piper Jaffray 39th Annual Consumer Marketplace Conference, Jefferies 2019 Healthcare Conferen... GlobeNewswire Inc. - 5/30/2019 11:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/29/2019 3:02:43 PM
Cronos Group Inc. Sets Date for 2019 Annual Meeting of Shareholders GlobeNewswire Inc. - 5/29/2019 1:30:00 PM
Ancillary Cannabis Stocks InvestorsHub NewsWire - 5/29/2019 11:56:35 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/28/2019 3:03:58 PM
CBD Surge Puts Pressure on Cultivation Supplies NetworkNewsWire - 5/28/2019 8:45:00 AM
MJ Deals Making Investors profits-THC Therapeutics, Inc. (THCT) InvestorsHub NewsWire - 5/22/2019 12:11:46 PM
Celebrity Attention Fuels Rising Press Profile of CBD NetworkNewsWire - 5/21/2019 8:45:00 AM
Hemp Companies Move to Tackle CBD Shortfall NetworkNewsWire - 5/14/2019 8:45:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/14/2019 7:02:28 AM
Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potenti... GlobeNewswire Inc. - 5/14/2019 7:01:00 AM
Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement GlobeNewswire Inc. - 5/14/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/9/2019 7:03:17 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/9/2019 7:02:21 AM
Cronos Group Inc. Announces First Quarter 2019 Results GlobeNewswire Inc. - 5/9/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/7/2019 8:02:29 AM
Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel GlobeNewswire Inc. - 5/7/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/19/2019 6:05:00 AM
Hemp Boom Spawns Lucrative Deals NetworkNewsWire - 4/17/2019 8:45:00 AM
Mainstream Acceptance, Strong Growth Adds to Growing CBD Market NetworkNewsWire - 4/11/2019 8:45:00 AM
Brodmann Member Level  Tuesday, 05/14/19 08:58:14 AM
Re: None
Post # of 5966 
$CRON get NICE mention in new report on the FDA CBD Trials

http://fortunenewswire.com/aurora-cannabis-acb-and-others-receive-price-upgrades-following-cbd-trial-update-research-results/

Quote:
Top Cannabis companies such as Aphria (NYSE:APHA), Cronos Group (NASDAQ:CRON), Canopy Growth (NYSE:CGC) and Aurora Cannabis (NYSE:ACB) are among the most anticipated cannabis stocks to monitor during these trials, which is set to take place in April to look into how the FDA might legalize CBD-additives in food products. These four cannabis giants stand to benefit significantly from a positive out-come of the trails, which ultimately aim to loosen the constraints of adding cannabis related products to food and drinks.


Come on baby, lets break out!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist